The US Food and Drug Administration warned on Monday that the Johnson & Johnson COVID-19 vaccines may increase the risk of Guillain-Barre syndrome, a rare neurological illness, after 100 early instances were identified among the 12.5 million doses given out.
According to a news report published on CNN, 95% of the instances were serious enough to necessitate hospitalisation and one person died, according to the organisation.
Johnson & Johnson said that it was discussing the matter with the US Centers for Disease Control and Prevention and the Food and Drug Administration.
The company said in a brief statement that the chance of having this occur is very low, and the rate of reported cases exceeds the background rate by a small degree.
.Guillain-Barré syndrome is a rare neurological illness in which the immune system targets nerves, resulting in temporary but possibly life-threatening paralysis.
The majority of people who develop GBS symptoms do so after contracting a respiratory infection, such as the flu or becoming ill with diarrhoea, according to the CDC.
A pathogen linked to eating raw poultry is one of the most common causes.
Discover more from LN247
Subscribe to get the latest posts sent to your email.
